[National guidelines for the prevention and control of diabetes in primary care (2022)].

The prevalence of diabetes in China has increased significantly, and about 11.9% of adults have diabetes. According to the report on chronic disease risk factor surveillance in China 2018, the rates of awareness, treatment and glycemic control of diabetes in China were only 38.0%, 34.1% and 33.1%, respectively. There are rigorous challenges existing in terms of diabetes prevention and glycemic control, especially in primary medical care. Under the guidance of National Health Commission of the People's Republic of China and Chinese Medical Association, National Office for Primary Diabetes Care issued the "National guidelines for the prevention and control of diabetes in primary care (2018)" in 2018. To improve the ability of primary health facilities and provide standardized basic public health and medical services throughout the country, the present guideline is released with updating the latest progresses in diabetes research and practice based on the 2018 edition. It is applicable to healthcare providers in primary care for type 2 diabetic patients over 18 years of age, and includes basic requirements for management, workflow of health management, diagnosis, treatment, identification and management of diabetic acute complications and chronic complications, traditional Chinese medicine, referral, and health management.近年来我国成人糖尿病患病率持续上升，已高达11.9%。2018年中国慢性病及危险因素监测报告显示，全国糖尿病知晓率、治疗率和控制率分别为38.0%、34.1%和33.1%，基层糖尿病防治任务艰巨。为了指导基层医务人员为居民提供综合性、连续性的糖尿病健康管理服务，在国家卫生健康委员会基层卫生健康司、中华医学会指导下，国家基层糖尿病防治管理办公室组织糖尿病相关领域及基层医疗卫生专家共同制定了《国家基层糖尿病防治管理指南（2018）》。本指南是在2018年版指南基础上结合国内外研究实践最新进展进行的更新，旨在进一步推动基层糖尿病健康管理工作的同质化与规范化。本指南适用于基层医疗卫生机构医务人员。管理人群包括辖区内18岁及以上的2型糖尿病患者。本指南主要内容包括管理基本要求、健康管理流程、诊断、治疗、急性并发症的识别与处理、慢性并发症检查、中医药防治、转诊及健康管理。.